# TL1A serves as a positive regulator to promote adipocyte differentiation

**Authors:** Ziqi Chang, Qiaoyu Wang, Yan Zhai, Ke Li, Xianjie Zheng, Yaohui Wang, Dan Zhao

PMC · DOI: 10.1371/journal.pone.0343036 · PLOS One · 2026-02-19

## TL;DR

This study shows that TL1A promotes the formation of fat cells by enhancing key signaling pathways involved in adipogenesis.

## Contribution

The study reveals a novel role of TL1A as a positive regulator of adipocyte differentiation through YAP1-mediated β-catenin signaling.

## Key findings

- TL1A treatment increased lipid droplet formation and adipogenic marker expression in MEFs and 3T3-L1 cells.
- TL1A enhanced YAP1 phosphorylation and inhibited β-catenin stabilization, affecting adipogenesis.
- Early and late-stage adipogenic genes were upregulated in response to TL1A treatment.

## Abstract

Adipogenesis, the intricate process of differentiation from preadipocytes or mesenchymal stem cells into mature adipocytes, is crucial for the formation and metabolic function of adipose tissues in mammals. The TNF ligand–related molecule 1A (TL1A) is a type II transmembrane protein belonging to the TNF superfamily. Inflammation is involved in the whole process of adipocyte cell formation and obesity development. To investigate the potential influence of TL1A on adipocyte development, we examined mouse embryo fibroblasts (MEFs) and 3T3-L1 cells. Our findings indicated that TL1A-treated MEFs exhibited an elevated rate of spontaneous adipogenesis, with a significant enhancement in adipocyte formation upon induction with a combination of insulin, dexamethasone and methylisobutylxanthine. This increased adipogenesis was evidenced by augmented lipid droplet formation and elevated expression of several adipogenic markers. Specifically, there was an upregulation of early-stage adipogenesis genes, including Krox20, KLF5, C/EBPβ and C/EBPδ, as well as late-stage adipogenesis regulators such as KLF15, C/EBPα, PPARγ and aP2. Moreover, TL1A significantly upregulated the protein expression of adipogenic markers (C/EBPα, C/EBPβ, PPARγ, CD36 and aP2) in MEFs and 3T3-L1 cells. Mechanistically, TL1A enhanced the phosphorylation of yes-associated protein 1 (YAP1), which led to cytoplasmic retention. Ultimately, TL1A inhibited the stabilization and nuclear transfer of β-catenin in MEFs, probably through regulating the upstream protein YAP1. Taken together, TL1A promoted adipogenic differentiation of MEFs and 3T3-L1 cells in vitro, which partly via inhibiting YAP1 mediated β-catenin signaling pathway.

## Linked entities

- **Genes:** EGR2 (early growth response 2) [NCBI Gene 1959], KLF5 (KLF transcription factor 5) [NCBI Gene 688], CEBPB (CCAAT enhancer binding protein beta) [NCBI Gene 1051], CEBPD (CCAAT enhancer binding protein delta) [NCBI Gene 1052], KLF15 (KLF transcription factor 15) [NCBI Gene 28999], CEBPA (CCAAT enhancer binding protein alpha) [NCBI Gene 1050], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], FABP4 (fatty acid binding protein 4) [NCBI Gene 2167], YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413], ctnnb1.S (catenin beta 1 S homeolog) [NCBI Gene 380441]
- **Proteins:** TNFSF15 (TNF superfamily member 15), CEBPA (CCAAT enhancer binding protein alpha), CEBPB (CCAAT enhancer binding protein beta), PPARG (peroxisome proliferator activated receptor gamma), CD36 (CD36 molecule (CD36 blood group)), FABP4 (fatty acid binding protein 4), YAP1 (Yes1 associated transcriptional regulator), ctnnb1.S (catenin beta 1 S homeolog)
- **Chemicals:** insulin (PubChem CID 70678557), dexamethasone (PubChem CID 5743), methylisobutylxanthine (PubChem CID 3758)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Slc2a4 (solute carrier family 2 (facilitated glucose transporter), member 4) [NCBI Gene 20528] {aka GT2, Glut-4, Glut4, twgy}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Fabp4 (fatty acid binding protein 4, adipocyte) [NCBI Gene 11770] {aka 422/aP2, AFABP, ALBP, ALBP/Ap2, Ap2, Lbpl}, Adipoq (adiponectin, C1Q and collagen domain containing) [NCBI Gene 11450] {aka 30kDa, APN, Acdc, Acrp30, Ad, Adid}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Plin1 (perilipin 1) [NCBI Gene 103968] {aka 6030432J05Rik, Peri, Plin}, Abca1 (ATP-binding cassette, sub-family A member 1) [NCBI Gene 11303] {aka ABC-1, Abc1}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Tfap2a (transcription factor AP-2, alpha) [NCBI Gene 21418] {aka AP-2, AP2alpha, Ap-2 (a), Ap2, Ap2tf, Tcfap2a}, Cebpa (CCAAT/enhancer binding protein alpha) [NCBI Gene 12606] {aka C/ebpalpha, CBF-A, Cebp}, Gm12551 (perilipin 2 pseudogene) [NCBI Gene 101055843], Klf5 (Kruppel-like transcription factor 5) [NCBI Gene 12224] {aka 4930520J07Rik, Bteb2, CKLF, IKLF}, Lpl (lipoprotein lipase) [NCBI Gene 16956], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Egr2 (early growth response 2) [NCBI Gene 13654] {aka Egr-2, Krox-20, Krox20, NGF1-B, Zfp-25, Zfp-6}, Yap1 (yes-associated protein 1) [NCBI Gene 22601] {aka Yap, Yap65, Yki, Yorkie}, Abcg1 (ATP binding cassette subfamily G member 1) [NCBI Gene 11307] {aka Abc8, White}, Lmna (lamin A) [NCBI Gene 16905] {aka Dhe}, Cebpd (CCAAT/enhancer binding protein delta) [NCBI Gene 12609] {aka c/EBPdelta}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Cebpb (CCAAT/enhancer binding protein beta) [NCBI Gene 12608] {aka C/EBPbeta, CRP2, IL-6DBP, LAP, LIP, NF-IL6}, Klf15 (Kruppel-like transcription factor 15) [NCBI Gene 66277] {aka 1810013I09Rik, CKLF, KKLF, hlb444}, Tnfsf15 (tumor necrosis factor (ligand) superfamily, member 15) [NCBI Gene 326623] {aka Tl1, Tl1a, Tnlg1b, Vegi}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}
- **Diseases:** adipose metabolic dysfunction (MESH:D008659), obesity (MESH:D009765), diabetes (MESH:D003920), cancer (MESH:D009369), hyperlipidemia (MESH:D006949), metabolic syndromes (MESH:D024821), Inflammation (MESH:D007249), inflammatory bowel diseases (MESH:D015212), cardiovascular disease (MESH:D002318), rheumatoid arthritis (MESH:D001172), atherosclerosis (MESH:D050197)
- **Chemicals:** isopropanol (MESH:D019840), cholesterol (MESH:D002784), water (MESH:D014867), TRIzol (MESH:C411644), Oil Red O (MESH:C011049), EDTA (MESH:D004492), nitrogen (MESH:D009584), streptomycin (MESH:D013307), TG (MESH:D014280), glucose (MESH:D005947), glutamine (MESH:D005973), lipid (MESH:D008055), paraformaldehyde (MESH:C003043), 3-Isobutyl-1-methylxanthine (MESH:D015056), Dexamethasone (MESH:D003907), oil (MESH:D009821), DMEM (-), penicillin (MESH:D010406)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), MEFs — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_6459)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12919779/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12919779/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12919779/full.md

---
Source: https://tomesphere.com/paper/PMC12919779